PerspectivePublished 23 Jul 2021

Impact of Fingolimod on Multiple Sclerosis

Authors: Mamatha Dereddy

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Fingolimod could be a sphingosine-1-phosphate receptor modulator that sequesters liquid body substanceocytes in lymph nodes preventing them from conducive to a reaction reaction. it's been reportable to scale back the speed of relapses in relapsing-remitting disseminated multiple sclerosis by or so common fraction over a biennial amount. Fingolimod was shown to be effective in experimental reaction rubor, six AN animal model of disseminated multiple sclerosis (MS), and later investigated in 2 clinical trial clinical trials for relapsingremitting (RR)MS. seven In these trials, fingolimod was incontestable to be a secure and effective drug.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Annals of Clinical and Laboratory Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAnnals of Clinical and Laboratory Research
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Mamatha Dereddy”